About Healthcare Innovation Failure

Healthcare Innovation Failure is the public-benefit problem at the centre of ICChange’s emerging collaboration with Villgro Africa, announced in June 2026 in connection with the Africa Health Tech Summit.

The issue is straightforward but often overlooked: useful health innovations do not always reach the people and health systems that need them most. New tools, care models, technologies, and clinical approaches may show promise in early use, but still fail to become part of routine care. They may be difficult to finance, maintain, govern, train around, procure, integrate into clinical workflows, or sustain locally.

ICChange is developing this work as a Problem Space initiative. That means the first task is not to promote a specific product, fund a single pilot, or select a preferred implementation partner. The first task is to clarify the system problem, understand why adoption fails, identify what conditions must be in place for responsible uptake, and shape an accountable pathway for future support.

This work is connected to Global SATO, an emerging pathway focused on surgical, anesthesia, trauma, and obstetric care. Global SATO is being developed to help address why promising health innovations in these areas often fail to become durable practice in underserved health systems.

Healthcare Innovation Failure Within the ICChange Platform

ICChange makes systemic change practical.

Healthcare Innovation Failure fits directly within ICChange’s value chain:

Clarify What Matters → Design What Works → Scale What Sticks

At this stage, the work sits mainly in Clarify What Matters. ICChange is working to understand the adoption gap, define the system barriers, identify the actors involved, and determine what kind of pathway could responsibly support future action.

Global SATO is the current working pathway through which this issue is being developed. It brings together complementary roles: ICChange contributes systems framing, pathway design, partnership coordination, and charitable capital stewardship; Villgro Africa contributes innovation ecosystem and venture-building experience in African contexts; and clinical contributors, including the Office of Global Surgery, may support problem validation and technical insight as roles are clarified.

The current focus is pathway development, not public implementation. As the work develops, it may help inform later stages of design, testing, and scaling. Those stages must be based on evidence, partner-role clarity, appropriate approvals, and accountable reporting.

The broader purpose is to help connect community need, clinical insight, innovation, capital, and implementation pathways in a more disciplined way. The work is not about innovation for its own sake. It is about whether useful innovation can become practical, sustained, and accountable in the health systems where it is most needed.

The System Problem

Many healthcare challenges are not caused only by the absence of ideas or technologies. In many cases, useful innovations already exist but cannot move through the system in a way that makes them reliable, affordable, maintainable, and locally owned.

An innovation may exist, but the system around it may not be ready. 

Common barriers can include limited financing, unclear procurement pathways, weak maintenance capacity, workforce training gaps, lack of fit with clinical workflows, fragmented funding, insufficient local ownership, and limited accountability once a pilot or donation period ends.

This is especially important in underserved and under-resourced health systems. In surgical, anesthesia, trauma, and obstetric care, failure to adopt and sustain useful innovations can contribute to delayed care, preventable harm, avoidable disability, financial hardship, and loss of dignity.

The issue is therefore larger than a funding gap. Funding alone does not solve it unless the conditions for responsible adoption are understood and strengthened.

Healthcare Innovation Failure responds to this gap by asking a different question: not only “what innovation should be funded?” but “what has to be true for useful innovation to become part of sustained care?”

Challenge Statement

How can ICChange help develop the Global SATO pathway so that underserved health systems, clinical partners, innovators, funders, and implementation actors can move promising surgical, anesthesia, trauma, and obstetric care innovations toward practical and sustained use, while protecting public benefit, local ownership, accountability, and evidence-based reporting?

Theory of Change

If healthcare innovation adoption is supported as a systems challenge, then the conditions for responsible uptake become clearer.

If the Global SATO pathway is strengthened, then ICChange and its partners can help connect clinical need, local insight, innovation, capital, governance, and implementation readiness with public-benefit outcomes for underserved and at-risk populations.

Over time, this can help shift fragmented innovation activity toward more coordinated, accountable, measurable, and sustainable pathways for health-system improvement.

What Healthcare Innovation Supports

Healthcare Innovation supports the development work required before responsible implementation can occur.

This may include clarifying the adoption problem, mapping barriers, identifying affected populations and systems, engaging relevant partners, assessing readiness, developing funder materials, shaping reporting logic, and preparing accountable pathway options.

Through the emerging Global SATO pathway, the work is intended to support practical questions such as:

• What prevents useful health innovations from becoming routine practice?
• Which barriers are technical, financial, operational, governance-related, or local-capacity related?
• What role should each partner play?
• What evidence is needed before funders are asked to support implementation?
• What reporting commitments are realistic and responsible?
• How can charitable support be stewarded in a way that protects public benefit and avoids unsupported claims?

Donation levels and contribution options, once available, will be provided through the relevant donation page.

High-Level Goals and Outcomes

Through Healthcare Innovation and the emerging Global SATO pathway, ICChange is working toward a clearer and more accountable approach to health-system innovation adoption.

This work is intended to support:

• A clearer understanding of why promising health innovations fail to become durable practice.
• A stronger public-benefit frame for supporting adoption-readiness in underserved health systems.
• Better alignment among funders, clinical contributors, innovation ecosystem actors, implementation partners, and communities.
• A more disciplined approach to deciding what should be funded, when, and under what accountability conditions.
• A pathway for future donor and funder support that is based on evidence, role clarity, local relevance, and reporting commitments.

ICChange will report on documented activity and will not claim specific health, product, patient, system, implementation, or long-term impact outcomes unless evidence supports them.

Why ICChange

ICChange is a Canadian impact platform that helps partners move from fragmented efforts to coordinated, lasting impact.

This work fits ICChange because the adoption gap is not a simple technical problem. It requires system framing, partner alignment, capital discipline, implementation awareness, and careful stewardship.

ICChange brings a platform approach that connects people, ideas, systems, and resources. Its role is to help clarify the problem, align the right actors, shape responsible pathways, and support learning over time.

For Healthcare Innovation Failure, that means helping ensure that support is not directed too quickly toward isolated activities before the conditions for responsible adoption are understood. It also means protecting donors, partners, and affected communities from unsupported claims about what funding will achieve.

The Villgro–ICChange collaboration provides an important context for this work. Villgro Africa brings experience with innovation ecosystems and venture support in African contexts. ICChange brings the charitable public-benefit frame, systems pathway development, partner coordination, and contribution stewardship needed to turn the adoption problem into a responsible giving pathway.

Together, the work is intended to help make health innovation more practical, more accountable, and more connected to long-term public benefit.

Find Out How to Support Healthcare Innovation

ICChange is currently developing a giving pathway connected to Healthcare Innovation Failure and the emerging Global SATO pathway.

This work is related to ICChange’s collaboration with Villgro Africa and is focused on preparing the responsible conditions for future health-system innovation adoption work.

To support this work, please visit the Healthcare Innovation donation page.

[Zeffy donation page link]

Contribution Note

Donations support ICChange’s charitable work connected to Healthcare Innovation Failure and the emerging Global SATO pathway. ICChange will steward contributions in alignment with its charitable purposes, approved pathway, and reporting commitments.

Specific health, patient, product, system, implementation, partner-delivery, or long-term impact outcomes will only be reported where evidence supports them.